Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection [5]

Hepatology

Volumn 46, Issue 2, 2007, Pages 606-607

  Papatheodoridis, George V ^a   Manesis, Emanuel K ^a   Manolakopoulos, Spilios ^a   Archimandritis, Athanasios J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

CLINICAL PRACTICE; DISEASE SEVERITY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER FIBROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS;

EID: 34548316975     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21864     Document Type: Letter

References (8)

1. Lok ASF, McMahon BJ. AASLD Practice Guidelines: Chronic hepatitis B. HEPATOLOGY 2007;45:507-539.
2. Chu C-J, Hussain M, Lok ASF. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. HEPATOLOGY 2002;36:1408-1415.
3. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-Summary of a workshop. Gastroenterology 2001;120:1828-1853.
4. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. HEPATOLOGY 2004;39:857-861.
5. Keeffe KB, Dieterich DT, Han S-HB, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006;4:936-962.
6. Papatheodoridis GV, Manesis EK, Manolakopoulos S, Goulis J, Chrysanthos N, Bilalis A, et al. Is there a meaningful serum HBV DNA cut-off level for therapeutic decisions in HBeAg-negative chronic hepatitis B (CHBe-)? [abstract] HEPATOLOGY 2006;44(Suppl. 1):541A.
7. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham B-N, Ollivier S, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-548.
8. Manesis E, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003;98:2261-2267.